Author

Shabiha Afroj Heeamoni

University of Arkansas for Medical SciencesORCID 0009-0008-8634-191XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

Md Mahbub Hasan· 2 shared Md Rafikul Islam· 2 shared Mohammad Alinoor RahmaniD· 2 shared Preeti NagariD· 2 shared Adrian R. KraineriD· 1 shared Israt Jahan MuktaiD· 1 shared Mokarram HossainiD· 1 shared Naomi McNaughton· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Md Mahbub Hasan

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyGenes & DevelopmentPeer-reviewedAug 3, 2026

Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction

Md Rafikul Islam, Preeti Nagar, Naomi McNaughton…·Mohammad Alinoor Rahman

This study identifies splicing dysregulation in SF-mutated cancers and demonstrates that antisense oligonucleotides can correct aberrant splicing and restore tumor suppressor function.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJul 29, 2026

CRISPR-mediated Correction of Oncogenic AS-NMD in Splicing Factor Mutant Cancer

Preeti Nagar, Md Rafikul Islam, Nirjhor Anuvob Rahman…·Mohammad Alinoor Rahman

This paper demonstrates CRISPR-mediated correction of oncogenic AS-NMD in splicing factor mutant cancer by deleting a poison exon from the tumor suppressor EZH2.

DOI 10.64898/2026.07.28.739648

humanexperimental assay

𝕏 PostBluesky